Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 9/20 | 0.47 |
| ▸ | DRD4 | P21917 | 5/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24508741 | 0.94 | DRD3 (0.46) | DRD3DRD4CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL9935633 | 0.92 | DRD3 (0.45) | DRD3DRD4CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL2357921 | 0.89 | EPHX1 (0.52) | DRD3DRD4CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL9935047 | 0.89 | EPHX1 (0.41) | DRD3DRD4CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL25565643 | 0.88 | DRD3 (0.51) | DRD3DRD4DRD2 | |
| SCHEMBL25565642 | 0.88 | DRD3 (0.51) | DRD3DRD4DRD2 | |
| SCHEMBL9935115 | 0.88 | DRD3 (0.47) | DRD3DRD4 | |
| SCHEMBL9801156 | 0.88 | DRD3 (0.51) | DRD3DRD4DRD2 | |
| SCHEMBL25110254 | 0.88 | DRD3 (0.42) | DRD3DRD4CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL25110755 | 0.88 | DRD3 (0.42) | DRD3DRD4CYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546609-B2 | Ionic liquid containing allylsulfonate anion | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| EP-2474527-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | Wako Pure Chemical Industries, Ltd. (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | ATXN2L, ARL1, INPPL1 | DRD3 812/4885DRD4 1086/4885CYP1A2 4011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.